TY - JOUR
T1 - Peripartum cardiomyopathy management
T2 - insights from a Latin American case report
AU - Torres-Valencia, Javier
AU - Zavaleta-Camacho, Gabriela
AU - Saucedo-Chinchay, José
AU - Alayo-Rojas, Karen
AU - Diaz-Arocutipa, Carlos
N1 - Publisher Copyright:
© 2024, National Cardiovascular Institute - INCOR. All rights reserved.
PY - 2024
Y1 - 2024
N2 - Peripartum cardiomyopathy (PPCM) is a potentially life-threatening condition that can occur during the late pregnancy or puerperium. A 31-year-old woman with a recent twin pregnancy presented with heart failure symptoms nine days postpartum. On admission, she had volume overload and hemodynamic compromise, which was rapidly reversed with inotropic levosimendan support. Echocardiography revealed a left ventricular ejection fraction (LVEF) of 20% with global hypokinesia. Once stabilized, she was discharged on heart failure medication, bromocriptine, and warfarin. Cardiac magnetic resonance imaging at five weeks demonstrated a preserved LVEF of 57% and no evidence of myocardial scarring or edema. During the 4-year follow-up, the patient remained stable with no new pregnancies. This case highlights the importance of considering PPCM in the differential diagnosis of heart failure in the peripartum period after excluding other etiologies. It also describes the successful use of bromocriptine in facilitating recovery of systolic function without long-term complications.
AB - Peripartum cardiomyopathy (PPCM) is a potentially life-threatening condition that can occur during the late pregnancy or puerperium. A 31-year-old woman with a recent twin pregnancy presented with heart failure symptoms nine days postpartum. On admission, she had volume overload and hemodynamic compromise, which was rapidly reversed with inotropic levosimendan support. Echocardiography revealed a left ventricular ejection fraction (LVEF) of 20% with global hypokinesia. Once stabilized, she was discharged on heart failure medication, bromocriptine, and warfarin. Cardiac magnetic resonance imaging at five weeks demonstrated a preserved LVEF of 57% and no evidence of myocardial scarring or edema. During the 4-year follow-up, the patient remained stable with no new pregnancies. This case highlights the importance of considering PPCM in the differential diagnosis of heart failure in the peripartum period after excluding other etiologies. It also describes the successful use of bromocriptine in facilitating recovery of systolic function without long-term complications.
KW - Cardiomyopathies
KW - Heart Failure
KW - Latin America
UR - http://www.scopus.com/inward/record.url?scp=85212510293&partnerID=8YFLogxK
U2 - 10.47487/apcyccv.v5i4.422
DO - 10.47487/apcyccv.v5i4.422
M3 - Artículo
AN - SCOPUS:85212510293
SN - 2708-7212
VL - 5
SP - 249
EP - 254
JO - Archivos Peruanos de Cardiologia y Cirugia Cardiovascular
JF - Archivos Peruanos de Cardiologia y Cirugia Cardiovascular
IS - 4
ER -